Department of Respiratory, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, 210000 Nanjing, Jiangsu, China.
Department of Respiratory, The Second Hospital of Lianyungang, 222000 Lianyungang, Jiangsu, China.
Front Biosci (Landmark Ed). 2024 Jan 18;29(1):27. doi: 10.31083/j.fbl2901027.
The pentose phosphate pathway (PPP) is a critical metabolic pathway that generates NADPH and ribose-5-phosphate for nucleotide biosynthesis and redox homeostasis. In this study, we investigated a potential regulatory role for Krüppel-like factor 8 (KLF8) in the control of PPP in lung adenocarcinoma (LUAD) cells.
Based on a comprehensive set of experimental approaches, including cell culture, molecular techniques, and functional assays, we revealed a novel mechanism by which KLF8 promotes the activation of glucose-6-phosphate dehydrogenase (G6PD), a component enzyme in the PPP.
Our findings demonstrate that KLF8 inhibits the acetylation of G6PD, leading to its increased enzymatic activity. Additionally, we observed that KLF8 activates the transcription of SIRT2, which has been implicated in regulating G6PD acetylation. These results highlight the interplay between KLF8, G6PD, and protein acetylation in the regulation of PPP in LUAD.
Understanding the intricate molecular mechanisms underlying the metabolic reprogramming driven by KLF8 in lung cancer provides valuable insights into potential therapeutic strategies targeting the PPP. This study emphasizes the significance of KLF8 as a key modulator of metabolic pathways and indicates the potential of targeting the KLF8-G6PD axis for lung cancer treatment.
戊糖磷酸途径(PPP)是一种关键的代谢途径,可生成 NADPH 和核糖-5-磷酸,用于核苷酸生物合成和氧化还原平衡。在这项研究中,我们研究了 Krüppel 样因子 8(KLF8)在肺腺癌(LUAD)细胞中 PPP 控制中的潜在调节作用。
基于包括细胞培养、分子技术和功能测定在内的一整套实验方法,我们揭示了 KLF8 促进葡萄糖-6-磷酸脱氢酶(G6PD),即 PPP 的组成酶激活的新机制。
我们的研究结果表明,KLF8 抑制 G6PD 的乙酰化,导致其酶活性增加。此外,我们观察到 KLF8 激活了 SIRT2 的转录,SIRT2 被认为参与调节 G6PD 的乙酰化。这些结果突出了 KLF8、G6PD 和蛋白质乙酰化在 LUAD 中 PPP 调节中的相互作用。
了解 KLF8 在肺癌中驱动代谢重编程的复杂分子机制为针对 PPP 的潜在治疗策略提供了有价值的见解。本研究强调了 KLF8 作为代谢途径关键调节剂的重要性,并表明靶向 KLF8-G6PD 轴治疗肺癌的潜力。